TAILIEUCHUNG - Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives

Non-Hodgkin lymphoma and its treatment can lead to other health problems. You may receive supportive care to prevent or control these problems and to improve your comfort and quality of life during treatment. You may receive antibiotics and other drugs to help protect you from infections. Your health care team may advise you to stay away from crowds and from people with colds and other contagious diseases. If an infection develops, it can be serious, and you will need treatment right away. Non-Hodgkin lymphoma and its treatment also can lead to anemia, which may make you feel very tired. Drugs or blood transfusions can help with this problem. . | Methods for Measuring Cancer Disparities Using Data Relevant to Healthy People 2010 Cancer-Related Objectives Sam Harper John Lynch Center for Social Epidemiology and Population Health University of Michigan Current contact information Department of Epidemiology Biostatistics and Occupational Health McGill University Purvis Hall Montreal QC H3A 1A2 Email Phone 514 398-6261 Fax 514 398-4266 This report was written under contract from the Surveillance Research Program SRP and the Applied Research Program ARP of the Division of Cancer Control and Population Sciences of the National Cancer Institute NIH. Additional support was provided by the Office of Disease Prevention in the Office of the Director at the National Institutes of Health. It represents the interests of these organizations in health disparities related to cancer quantitative assessment and monitoring of these disparities and interventions to remove them. NCI Project Officers for this contract are Marsha E. Reichman . SRP Bryce Reeve . ARP and Nancy Breen . ARP . Table of Contents Executive Initiatives to Eliminate Health Brief History of Measuring Disparities in the United Health Inequality and Health Defining Health Disparities .17 Issues in Evaluating Measures of Health Total Disparity vs. Social-Group Relative and Absolute Reference Social Groups and Natural The Number of Social Groups .25 Population Size . 27 Socioeconomic Dimension . 28 Monitoring Over Time .29 Transfers . 29 Subgroup Decomposability .30 Scale Independence . 30 Transparency Interpretability for Policy Makers . 31 iii Measures of Health Disparity . 33 Measures of Total Measures of Social-Group Measures of Average Disproportionality .47 Choosing a Suite of Health Disparity Summary Indicators .62 Appendix .

• Y học thường thức
• Malignant Gliomas
• Radioresistant Glioblastoma
• Radiobiology
• Therapeutic Stresses
• Glioma Progression
• Progression and Therapy
• Haemorrhage tumor
• Crucial features
• Heterogeneous intense
• Vivid enhancement
• Chemokine Responses
• Hepatitis C Virus
• Treatment Responses
• trình bày báo cáo
• tài liệu báo cáo khoa học
• báo cáo y học
• kiến thức y học
• nghiên cứu y học
• medical reports
• thesis report
• traditional medicine
• Structural biochemistry
• oxidation
• bacteria